Judge Postpones Hearing On Pfizer Bid To Block Neurontin Generic

Law360, New York (September 27, 2004, 12:00 AM EDT) -- A court hearing on a motion by drug maker Pfizer Inc. to bar Alpharma Inc. from rolling out a generic version of the Pfizer epilepsy drug Neurontin has been postponed until Oct. 1, Alpharma said on Monday.

Judge John C. Lifland of the U.S. District Court for the District of New Jersey denied a Pfizer request which would have prohibited an Alpharma launch until the date of a decision on the preliminary injunction.

Alpharma said it continues to “review its options regarding gabapentin, including a launch...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.